{"id":89723,"date":"2026-07-01T17:17:56","date_gmt":"2026-07-01T21:17:56","guid":{"rendered":"https:\/\/tvdelmarva.com\/wp\/federal-judge-blocks-colorados-groundbreaking-price-cap-on-arthritis-drug-enbrel\/"},"modified":"2026-07-01T17:17:56","modified_gmt":"2026-07-01T21:17:56","slug":"federal-judge-blocks-colorados-groundbreaking-price-cap-on-arthritis-drug-enbrel","status":"publish","type":"post","link":"https:\/\/tvdelmarva.com\/wp\/federal-judge-blocks-colorados-groundbreaking-price-cap-on-arthritis-drug-enbrel\/","title":{"rendered":"Federal Judge Blocks Colorado’s Groundbreaking Price Cap on Arthritis Drug Enbrel"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n

A federal judge has put the brakes on what would have been the first state-imposed price cap on a prescription drug in the United States, blocking Colorado from limiting the cost of Amgen’s widely used arthritis medication Enbrel.<\/p>

Chief Judge Daniel Domenico of the Denver federal court issued the preliminary injunction on Wednesday, finding that forcing Amgen to sell Enbrel at a lower price would likely cause the company serious and irreparable financial damage. The judge noted the cap could also disrupt Amgen’s future contract negotiations with wholesalers and distributors.<\/p>

In his ruling, Domenico wrote that “as a matter of basic economic logic, Amgen is likely to be significantly harmed by a cap on the price of its product, even if the cap applies unevenly” throughout the supply chain.<\/p>

The judge acknowledged that Colorado has a legitimate interest in making Enbrel more affordable for patients. He suggested the state could pursue alternatives such as subsidies or price negotiations \u2014 similar to approaches used at the federal level \u2014 but concluded that “capping the price of a patented drug” was not a legally permissible path.<\/p>

Last October, the Colorado Prescription Drug Affordability Board had set an Enbrel price ceiling of $600 for a 50-milligram weekly dose, which works out to $31,200 annually. That cap was set to take effect on January 1, 2027. Amgen had been facing a July 5 deadline to decide whether it would continue offering the drug in Colorado at all.<\/p>

Enbrel, known chemically as etanercept, treats arthritis and plaque psoriasis and is one of Amgen’s top-selling products, generating $2.23 billion in sales in 2025. Its current list price tops $100,000 per year.<\/p>

The Thousand Oaks, California-based pharmaceutical company had argued that Colorado’s price cap conflicted with federal patent law, violated its constitutional due process rights, and put patients’ access to the medication at risk.<\/p>

A spokeswoman for Colorado’s Division of Insurance, Genna Morton, said the agency is unable to comment while the case is ongoing. Representatives for Amgen and its legal team did not respond to requests for comment.<\/p>

The case highlights a broader challenge facing American consumers: the U.S. spends roughly three times what other wealthy nations pay for brand-name medications, prompting both federal and state governments to seek ways to bring those costs down.<\/p>

Judge Domenico was appointed to the federal bench by Donald Trump. The president has since nominated him to serve on the 10th U.S. Circuit Court of Appeals, which has jurisdiction over Colorado.<\/p>","protected":false},"excerpt":{"rendered":"

A federal judge has halted Colorado’s unprecedented attempt to cap the price of Amgen’s popular arthritis drug Enbrel, which carries a list price exceeding $100,000 per year. The state had set a cap of $600 per weekly dose, but a preliminary injunction was granted after the court determined Amgen would likely suffer significant and irreparable financial harm. The ruling raises broader questions about how states can legally address skyrocketing prescription drug costs.<\/p>\n","protected":false},"author":4,"featured_media":89722,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[837],"tags":[],"class_list":["post-89723","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/07\/news-1782940676187.jpg?fit=450%2C300&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pbtNqq-nl9","jetpack-related-posts":[{"id":87209,"url":"https:\/\/tvdelmarva.com\/wp\/european-drug-agency-moves-to-pull-amgens-rare-disease-treatment-from-market\/","url_meta":{"origin":89723,"position":0},"title":"European Drug Agency Moves to Pull Amgen’s Rare Disease Treatment from Market","author":"Admin","date":"June 26, 2026","format":false,"excerpt":"Europe's top medicines regulator has recommended pulling Amgen's rare autoimmune disease drug Tavneos from the market, saying its risks outweigh its benefits. The move follows a similar action by U.S. regulators earlier this year, who flagged dozens of cases of serious liver injury linked to the drug. Patients currently on\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1782476191077.jpg?fit=450%2C316&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":58389,"url":"https:\/\/tvdelmarva.com\/wp\/federal-regulators-move-to-pull-amgen-drug-over-safety-concerns-deaths\/","url_meta":{"origin":89723,"position":1},"title":"Federal Regulators Move to Pull Amgen Drug Over Safety Concerns, Deaths","author":"Admin","date":"April 27, 2026","format":false,"excerpt":"The FDA is seeking to revoke approval for an Amgen medication used to treat rare autoimmune conditions after discovering serious liver complications and eight deaths. The agency also found the original approval was based on misleading information and the drug lacks proven effectiveness.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/04\/news-1777340268304.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":87406,"url":"https:\/\/tvdelmarva.com\/wp\/fda-rejects-new-gout-treatment-over-manufacturing-concerns\/","url_meta":{"origin":89723,"position":2},"title":"FDA Rejects New Gout Treatment Over Manufacturing Concerns","author":"Admin","date":"June 26, 2026","format":false,"excerpt":"The U.S. Food and Drug Administration has refused to approve a new therapy for uncontrolled gout made by Swedish drugmaker Sobi. The agency cited concerns about manufacturing controls and deficiencies at contract facilities, though no safety or effectiveness issues were identified. About 200,000 Americans are estimated to suffer from uncontrolled\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1782505032272.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":80319,"url":"https:\/\/tvdelmarva.com\/wp\/pharmaceutical-giant-enlists-independent-firm-to-review-controversial-drug-data\/","url_meta":{"origin":89723,"position":3},"title":"Pharmaceutical Giant Enlists Independent Firm to Review Controversial Drug Data","author":"Admin","date":"June 11, 2026","format":false,"excerpt":"Amgen has hired an independent research organization to examine data for its drug Tavneos after federal regulators proposed removing it from the market. The FDA cited concerns about effectiveness and safety, including liver injuries and deaths linked to the medication.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781223821251.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":36567,"url":"https:\/\/tvdelmarva.com\/wp\/major-drug-companies-join-trump-administrations-prescription-website\/","url_meta":{"origin":89723,"position":4},"title":"Major Drug Companies Join Trump Administration’s Prescription Website","author":"Admin","date":"March 13, 2026","format":false,"excerpt":"Two pharmaceutical giants, GSK and Amgen, are partnering with the Trump administration's prescription drug platform called TrumpRX. The announcement was reported by Fox Business on Friday.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773451299559.png?fit=1200%2C675&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773451299559.png?fit=1200%2C675&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773451299559.png?fit=1200%2C675&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773451299559.png?fit=1200%2C675&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773451299559.png?fit=1200%2C675&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":40203,"url":"https:\/\/tvdelmarva.com\/wp\/small-cap-stocks-near-correction-territory-as-middle-east-tensions-drive-market-fears\/","url_meta":{"origin":89723,"position":5},"title":"Small-Cap Stocks Near Correction Territory as Middle East Tensions Drive Market Fears","author":"Admin","date":"March 20, 2026","format":false,"excerpt":"The Russell 2000 small-cap index has fallen 10% from its January peak, approaching correction territory amid rising inflation concerns linked to Middle East conflicts. Federal Reserve officials have adopted a more cautious stance on interest rate cuts, with market expectations now pointing to potential reductions only in the coming year.","rel":"","context":"In "Business"","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1774036286200.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/89723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/comments?post=89723"}],"version-history":[{"count":0,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/89723\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media\/89722"}],"wp:attachment":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media?parent=89723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/categories?post=89723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/tags?post=89723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}